PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Koncept Analytics

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Koncept Analytics Publishes Global LVAD Market Report - 2011 Edition - The current report analyzes the global LVAD market with special reference to the US LVAD market. It also analyzes the factors that are likely to drive the LVAD market in the coming years, along with the key issues faced by the industry
Koncept Analytics Publishes Global LVAD Market Report - 2011 Edition

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2011/07/26 - The current report analyzes the global LVAD market with special reference to the US LVAD market. It also analyzes the factors that are likely to drive the LVAD market in the coming years, along with the key issues faced by the industry.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Heart Failure is a progressive disease that is not reversible, and the only way to recover from the severe heart failure is to receive a heart transplant. In order for a heart transplant to occur, a patient has to wait till a matching heart donor is not found. During this wait time, the patient uses the Left Ventricular Assist Device to assist in the functioning of the failing heart. In this case, LVAD implantation is performed in order to extend the patient’s life until a suitable donor is found, and this makes LVADs suitable for the BTT or Bridge-to-transplant market. Another industry in which LVADs find application is the DT or Destination therapy market. DT patients are those who have heart failures but are not eligible for heart transplants, may be due to their ages or some other illness that might get aggravated by heart transplantations. In such cases, the patients have to use the LVADs till they survive.

Though some drug treatments and pacing devices are also available to address the heart failure disorder yet they can not stop the progression of this disease. Other devices and cell-based therapies are either in the early stages of development or have shown no fruitful results in achieving the desired results. All these factors have made ventricular assist devices (VADs) an increasingly accepted viable long term treatment option.

The start of the modern LVAD era began with the introduction of the HeartMate XVE in 1998. During the succeeding decade, vast improvements in pump design resulted in new crop of LVADs whose attributes are not only transforming LVAD therapy into the standard-of-care for end-stage heart failure, but also opening a potentially multi-billion dollar market for device manufacturers.

North America has been the largest market for LVADs and account for more than two-thirds of the global market. Despite this, the North American LVAD market still remains underpenetrated.

The report broadly includes the following

1. Heart Failure

2. LVAD Market
2.1 Global LVAD Market
2.2 US LVAD Market

3. Market Drivers

4. Key Issues

5. LVAD Market - Competitive Landscape

6. Company Profiles
6.1 Thoratec Corporation
6.2 Heartware International Inc.
6.3 World Heart Corporation

List of Charts
Types of Heart Failure
Global LVAD Market Estimates (2009-2014E)
LVAD Pumps Sold Worldwide (2010E-2014E)
Global LVAD Market – Value Share by Region (2009)
US Heart Transplant Donor Shortage (2001-2009)
Ageing Population (with ages greater than 55 years) Worldwide (2003-2010)
LVAD Reimbursement Trend in the US (2002-2009)
Possible Scenarios of the Global LVAD Competitive Landscape
Global LVAD Market – Share by Leading Companies (2009-2014)
US LVAD Market – Volume Share by Leading Companies (2008-2014E)
EU VAD Market Share by Companies (2008-2013E)
Thoratec Corporation Revenue (2006-2010)
Thoratec Corporation Revenue-Share Breakdown by Region (2010)
Heartware International Revenue (2008-2010)
Heartware International Revenue – Share Breakdown by Region (FY10)
World Health Corporation Revenue (2008-2010)
World Health Corporation Revenue – Share by Sources (2010)

List of Tables
Stages of Heart Failure by AHA and ACC
NYHA Classification of Heart Failure
Global LVAD Market Statistics – by Application Area & Company (2010E-2014E)
US LVAD Market - by Value and Volume (2008-2014E)
LVAD Market Opportunity analysis in the US (2009-2014E)
Cost Effectiveness of LVADs (1998-2008)
CPT Codes for VAD Implantation
Product Comparison in LVAD Market.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Koncept Analytics

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Koncept Analytics Publishes Global LVAD Market Report - 2011 Edition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Vikas Gupta - KonceptAnalytics.com 
+91-120-4130959 vikas[.]konceptanalytics.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Koncept Analytics securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Koncept Analytics / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)